A Regina mother who was one of the first ALS patients to test a new treatment is now celebrating its accelerated approval in ...

Analysts have set 12-month price targets for Voyager Therapeutics, revealing an average target of $18.93, a high estimate of ...

Pete Stavropoulos; Analyst; Cantor Fitzgerald & Co. Good afternoon and welcome to Voyager Therapeutics fourth-quarter and year-end 2024 financial results conference call. (Operator Instructions) ...

It was October 2024, and my husband Andrew had just been diagnosed with motor neurone disease (MND) aged 51 – which affects ...

March 11, 2025Voyager Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.59 EPS, expectations were ...

On Slide 4, you can see our pipeline. I won't go into a lot of detail here, other than to point out that our SOD1 silencing gene therapy program did move back into the research stage, as we ...

Tau silencing gene therapy VY1706 robustly reduced tau mRNA levels, with broad distribution, and was well-tolerated in NHP ...

Gene was suffering from severe heart disease and advanced Alzheimer's disease, while Betsy suffered from hantavirus, which is spread through rodent droppings Gene Hackman's wife Betsy Arakawa ...

The mystery surrounding Oscar-winning actor Gene Hackman's death has been solved. The 94-year-old died of heart disease and complications caused by Alzheimer’s disease, according to the New ...

Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...